Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Sainz

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Gut|June 22, 2016
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancerPaola Martinelli, Enrique Carrillo-de Santa Pau, Trevor Cox, et al.
Stem Cells International|July 9, 2019
MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>Karolin Walter, Kanishka Tiwary, Marija Trajkovic-Arsic, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2024
Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolismEduardo Ibello, Federica Saracino, Donatella Delle Cave, et al.
Gastroenterology|August 17, 2014
Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in micePatrick C Hermann, Patricia Sancho, Marta Cañamero, et al.
Cancers|March 25, 2022
Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)Raúl Muñoz Velasco, Paula Jiménez Sánchez, Ana García García, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 28, 2023
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivityQuan Zheng, Jiajia Tang, Alexandra Aicher, et al.
Scientific Reports|April 16, 2026
A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinomaKanishka Tiwary, Anton Lahusen, Syeda Inaas, et al.
Nature Communications|May 31, 2020
ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticitySonia Alcalá, Patricia Sancho, Paola Martinelli, et al.
Journal of Biomedical Science|July 7, 2026
Aptamer-based inhibition of MNK1 reduces pancreatic ductal adenocarcinoma growth by targeting cancer stem cellsAlberto Pérez-Ruiz, Laura Ruiz-Cañas, Sandra Batres, et al.
Gut|April 5, 2015
Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartmentBruno Sainz, Sonia Alcala, Elena Garcia, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Gut|June 22, 2016
GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancerPaola Martinelli, Enrique Carrillo-de Santa Pau, Trevor Cox, et al.
Stem Cells International|July 9, 2019
MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells <i>In Vitro</i> and <i>In Vivo</i>Karolin Walter, Kanishka Tiwary, Marija Trajkovic-Arsic, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 14, 2024
Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolismEduardo Ibello, Federica Saracino, Donatella Delle Cave, et al.
Gastroenterology|August 17, 2014
Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in micePatrick C Hermann, Patricia Sancho, Marta Cañamero, et al.
Cancers|March 25, 2022
Targeting BPTF Sensitizes Pancreatic Ductal Adenocarcinoma to Chemotherapy by Repressing ABC-Transporters and Impairing Multidrug Resistance (MDR)Raúl Muñoz Velasco, Paula Jiménez Sánchez, Ana García García, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 28, 2023
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivityQuan Zheng, Jiajia Tang, Alexandra Aicher, et al.
Scientific Reports|April 16, 2026
A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinomaKanishka Tiwary, Anton Lahusen, Syeda Inaas, et al.
Nature Communications|May 31, 2020
ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticitySonia Alcalá, Patricia Sancho, Paola Martinelli, et al.
Journal of Biomedical Science|July 7, 2026
Aptamer-based inhibition of MNK1 reduces pancreatic ductal adenocarcinoma growth by targeting cancer stem cellsAlberto Pérez-Ruiz, Laura Ruiz-Cañas, Sandra Batres, et al.
Gut|April 5, 2015
Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartmentBruno Sainz, Sonia Alcala, Elena Garcia, et al.
Pageof 10